Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis

May 13, 2024 updated by: Ankara City Hospital Bilkent

Evaluation of The Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis

Objective: The aim of the present study was to investigate the treatment efficacy of TECAR therapy, a modern application that has been increasingly used in recent years, compared to conventional physical therapy applications in the treatment of knee osteoarthritis, according to the evaluation of the clinical findings of patients.

Methods: A total of 54 patients, aged between 40 and 75 years, were randomly divided into two groups. Both groups received CPT. Group 2 received TECAR therapy in addition to CPT, applied three times a week for two weeks, for a total of 6 sessions. All patient's knee joint range of motion (ROM) was measured goniometrically, isometric quadriceps muscle strength was measured, and pain levels were assessed using the Visual Analog Scale (VAS), and disability levels were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) before treatment, at the end of treatment, at 1 month, and at 3 months.

Study Overview

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Özge TEZEN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 3 months of conservative treatment for unresponsive knee pain
  • Kellgren-Lawrence grade 2-3 on radiographic evaluation
  • Agreed to participate in the study.

Exclusion Criteria:

  • History of physical therapy (electrotherapy/exercise) in the past 3 months
  • Intra-articular injection therapy in the past 3 months,
  • History of surgery or trauma to the affected knee
  • Inflammatory or neurological disease affecting the lower extremities
  • Active vasculitis or severe peripheral vascular disease
  • Pregnancy or lactation
  • Diagnosed restless legs syndrome
  • Neoplasia
  • Local sensory impairment,
  • Local or systemic acute infections
  • Severe osteoporosis
  • Pacemaker
  • Psychiatric disorder and cognitive impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: conventional physical therapy (CPT)
Group 1 (HP, TENS, knee isometric and theraband exercise) to painful side knee area, two weeks, five times a week, 10 sessions.
10 sessions of HP and TENS for two weeks, five times a week. HP was applied to the painful knee area for 20 minutes using a heating pad for superficial heating purposes. TENS was applied to the painful knee area for 20 minutes at 80 Hz frequency
Experimental: conventional physical therapy (CPT) and TECAR therapy
Group 2 (HP, TENS, knee isometric and theraband exercise) 10 sessions, two weeks, five times a week and in addition TECAR therapy, to painful side knee quadriceps and peripatellar area, three times a week for two weeks, for a total of 6 sessions.
Transfer Energy Capacitative and Resistive Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS)
Time Frame: Before and the after treatment 0th day , 1th month, 3rd month
0 min , 10 is maximum pain score
Before and the after treatment 0th day , 1th month, 3rd month
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Time Frame: Before and the after treatment 0th day, 1th month, 3rd month
This 24-item index comprises three subscales: pain, stiffness, and physical function, each measured on a five-point Likert scale ranging from "none" to "extreme."
Before and the after treatment 0th day, 1th month, 3rd month
Range of Motion (ROM)
Time Frame: Before and the after treatment 0th day, 1th month, 3rd month
Flexion and extension of the knee joint were measured using a universal goniometer relative to reference points.
Before and the after treatment 0th day, 1th month, 3rd month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Diers Myoline Isometric Muscle Strength Measurement System
Time Frame: Before and the end of treatment 0th day, 1th month, 3rd month
quadriceps muscle Isometric Strength Measure: Increased isometric muscle strength is an indicator of recovery.
Before and the end of treatment 0th day, 1th month, 3rd month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2023

Primary Completion (Actual)

August 23, 2023

Study Completion (Actual)

November 23, 2023

Study Registration Dates

First Submitted

May 6, 2024

First Submitted That Met QC Criteria

May 13, 2024

First Posted (Actual)

May 17, 2024

Study Record Updates

Last Update Posted (Actual)

May 17, 2024

Last Update Submitted That Met QC Criteria

May 13, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

participant data will not share

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on conventional physical therapy; Transcutaneous Electrical Nerve Stimulation, hotpack

3
Subscribe